Synthetic vaccine against foot-and-mouth disease based on a palmitoyl derivative of the VP1 protein 135–159 fragment of the A22 virus strain
- 31 October 1996
- Vol. 14 (14) , 1375-1380
- https://doi.org/10.1016/s0264-410x(96)00038-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effect of a lipopeptidic formulation on macrophage activation and peptide presentation to T cellsVaccine, 1994
- New virus‐specific T‐helper epitopes of foot‐and‐mouth disease viral VP1 proteinFEBS Letters, 1993
- Fully synthetic immunogensInternational Journal of Peptide and Protein Research, 1991
- Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virusVaccine, 1990
- Polyvalent synthetic vaccines: relationship between T epitopes and immunogenicityVaccine, 1990
- Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activatorVaccine, 1989
- Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinantsNature, 1987
- An SN2 deprotection of synthetic peptides with a low concentration of hydrofluoric acid in dimethyl sulfide: evidence and application in peptide synthesisJournal of the American Chemical Society, 1983
- Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequenceNature, 1982
- A new synthetic route to tert-butyloxycarbonylaminoacyl-4-(oxymethyl)phenylacetamidomethyl-resin, an improved support for solid-phase peptide synthesisThe Journal of Organic Chemistry, 1978